✦ LIBER ✦

Design and Novel Synthesis of Aryl-heteroaryl-imidazole MAP Kinase Inhibitors.

✍ Scribed by Markus R. Dobler

Publisher: John Wiley and Sons
Year: 2003
Weight: 171 KB
Volume: 34
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200352126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Synthesis of Potent Pyridazin

Design and Synthesis of Potent Pyridazine Inhibitors of p38 MAP Kinase.

✍ Nuria Tamayo; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 42 KB

Design and Synthesis of Potent, Orally B

Design and Synthesis of Potent, Orally Bioavailable Dihydroquinazolinone Inhibitors of p38 MAP Kinase.

✍ John E. Stelmach; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 156 KB

Discovery and Design of Benzimidazolone

Discovery and Design of Benzimidazolone Based Inhibitors of p38 MAP Kinase.

✍ Neil Moss; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 20 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Design and Synthesis of Novel Epidermal

Design and Synthesis of Novel Epidermal Growth Factor Receptor Kinase Inhibitors.

✍ Jae Du Ha; Seung Kyu Kang; Kun-Do Kim; Joong-Kwon Choi; Jae Yang Kong; Chang H. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 10 KB

Design and Synthesis of a Focused Librar

Design and Synthesis of a Focused Library of Novel Aryl- and Heteroaryl-Ketopiperazides

✍ Matthias Gerlach; Eckhard Claus; Silke Baasner; Gilbert Müller; Emmanuel Polymer 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

## Abstract 1‐Phenyl‐4‐piperazinyl‐carbonyl‐substituted nitrogen‐containing heterocycles were discovered at Zentaris as a new class of potent, synthetic, small molecule tubulin inhibitors with strong antiproliferative activity. The lead structure of this class, **D‐24203**, proved to be a potent in

Novel, Potent and Selective Anilinoquina

Novel, Potent and Selective Anilinoquinazoline and Anilinopyrimidine Inhibitors of p38 MAP Kinase.

✍ John G. Cumming; Caroline L. McKenzie; Stuart G. Bowden; Douglas Campbell; David 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 15 KB